Single-dose & Repeated Dose Toxicity Testing

Single-dose & Repeated Dose Toxicity Testing

Prisys Biotech's experts in single-dose and repeated-dose studies provide vital safety assessments, including detailed endpoint evaluations. Ask our team about study design today
Send Inquiry
Product Introduction

Prisys Biotech provides comprehensive single-dose and repeated-dose toxicity testing services, essential for robust safety assessments during drug development. These studies are critical for informing key development decisions and mitigating risk prior to clinical trials. Our experienced team of toxicologists and clinicians collaborate closely to design and execute studies tailored to your specific needs.

 

Single-Dose Toxicity Testing

 

Single-dose toxicity studies determine the adverse effects of a substance following a single administration. This crucial data helps establish the initial toxicity profile of a drug candidate and informs further study designs.

 

Repeated-Dose Toxicity Testing

 

Repeated-dose toxicity studies assess the effects of a substance following multiple administrations over a specified period, typically ranging from 2 to 6 weeks. These studies are pivotal for evaluating the safety profile of a drug candidate, identifying potential target organ toxicities, and characterizing the reversibility of adverse effects.

 

Study Design & Implementation

 

Our team collaborates with drug development teams to determine the optimal study design for your specific compound. Considerations include:

  • Species Selection: Choosing the most relevant species (non-rodent, or non-human primate) for your test article.
  • Treatment Group Size: Determining the appropriate group size for statistical analysis and robust data.
  • Duration of Treatment: Selecting an appropriate dosing period based on the intended clinical use and expected effects.
  • Route of Administration: Choosing a relevant route that aligns with clinical application.
  • In-life Observations: Monitoring animals for clinical signs of toxicity.
  • Terminal Endpoints: Defining specific endpoints, including histopathology, clinical chemistry, and biomarker evaluation.
  • Biomarker Identification: Identifying and assessing relevant translational biomarkers that can be used in clinical trials to minimize risk.

 

Specialized Endpoints

Prisys Biotech offers specialized endpoints based on the pharmacology of the test article. Our toxicology laboratory services provide comprehensive analysis, ensuring a complete understanding of the toxicological effects.

Prisys Biotech is committed to providing reliable and accurate single-dose and repeated-dose toxicity data to support your drug development program. Contact us to discuss how our services can help you meet your regulatory and safety requirements.

 

Frequently Asked Questions (FAQ)

Q: What is the typical duration of a repeated-dose toxicity study?

A: Repeated-dose toxicity studies at Prisys Biotech typically range from 2 to 6 weeks, but the duration may be adjusted based on the specific test article and study requirements.

Q: How are species selected for toxicity studies?

A: Species selection is determined by considering various factors such as the relevance of the model to the intended clinical use, the compound's pharmacology, and regulatory guidelines. Our team will work with you to choose the most appropriate species for your specific study.

Q: What types of endpoints are typically evaluated in repeated-dose toxicity studies?

A: Endpoints evaluated include in-life clinical observations, clinical chemistry, hematology, histopathology, and biomarker analysis. Specialized endpoints can also be evaluated based on the specific properties of the test article.

Q: Can you help with the design of a repeated-dose toxicity study?

A: Yes, our team of experienced toxicologists and clinicians collaborates with our clients to design studies that are tailored to the unique properties of the test article and meet the specific needs of each drug development program.

Q: Do you conduct studies under GLP conditions?

A: We conduct non-GLP studies internally at Prisys Biotech. For GLP-compliant studies, we collaborate with external partner institutions.

Q: How can I get in touch for more information?

A: For more information, please contact us at info@prisysbiotech.com or visit our website at www.prisysbiotech.com.

 

 

 

 

Hot Tags: single-dose & repeated dose toxicity testing, research, study, monkey, gene therapy, laboratory of toxicology, Immunotoxicity, safety pharmacology, glp tox, in vivo toxicity, nucleotide PD

Send Inquiry

whatsapp

Phone

E-mail

Inquiry